Table 3.

a: Comparison of Outcomes After LVRS in STS Database Versus NETT

Outcomes	STS a	All NETT	Difference		P valueb
	%	%	%| Δ|	(95%CI)
30day Mortality †	5.6%	3.6%	2.0%	(−0.5% to 4.5%)	0.113
Table 3b: Comparison of Outcomes After LVRS in STS Database Versus Non-High Risk NETT Subset
Outcomes	STS a	Non-high Risk NETT Subset	Difference		P value b
	%	%	%| Δ|	(95%CI)
30day Mortality †	5.6%	2.2%	3.4%	(1.0% to 5.7%)	0.005
Re-admit to ICU ‡	7.8%	11.7%	3.9%	(−8.8% to 1.0%)	0.156
Sepsis ‡	1.9%	2.5%	0.6%	(−2.5% to 1.3%)	0.544
Arrhythmia ‡	16.2%	18.6%	2.4%	(−7.5% to 2.6%)	0.350
MI ‡	1.1%	1.0%	0.1%	(−1.3% to 1.4%)	0.910
Ventilator>48hrs ‡	4.6%	13.6%	9.1%	(−12.7% to −5.4%)	<0.001
Re-intubation ‡	12.9%	21.8%	8.9%	(−13.8% to −3.9%)	<0.001
Table 3c: Comparison of Outcomes After LVRS in STS Database Versus NETT Subset with Upper-Lobe Predominant Disease & Low Exercise Tolerance
Outcomes	STS a	NETT, Upper Lobe Disease ↓Exercise Tolerance	Difference		P value b
	%	%	%| Δ|	(95%CI)
30day Mortality †	5.6%	1.4%	4.2%	(1.4% to 7.0%)	0.039

^aMissing STS observations excluded;

^bP values from chi-squared tests;

^‡Referenced from Naunheim et al. 2006 ;

^†Referenced from Fishman et al. 2003